联邦制药(03933)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03933 联邦制药

午间休市 12-30 12:00:00

12.320

+0.060

+0.49%

最高12.440	最低12.200	成交量120.79万
今开12.240	昨收12.260	日振幅1.96%
总市值223.86亿	流通市值223.86亿	总股本18.17亿
成交额1,491万	换手率0.07%	流通股本18.17亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03933","market":"HK","secType":"STK","nameCN":"联邦制药","latestPrice":12.32,"timestamp":1735531200019,"preClose":12.26,"halted":0,"volume":1207900,"delay":0,"floatShares":1817026508,"shares":1817026508,"eps":1.5794877429842336,"marketStatus":"午间休市","change":0.06,"latestTime":"12-30 12:00:00","open":12.24,"high":12.44,"low":12.2,"amount":14906060,"amplitude":0.019576,"askPrice":12.36,"askSize":48000,"bidPrice":12.3,"bidSize":6000,"shortable":3,"etf":0,"ttmEps":1.700467847908273,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735534800000},"marketStatusCode":3,"adr":0,"exchange":"SEHK","adjPreClose":12.26,"dividendRate":0.053503,"openAndCloseTimeList":[[1735522200000,1735531200000],[1735534800000,1735545600000]],"volumeRatio":0.48199,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03933","defaultTab":"news","newsList":[{"id":"2493261607","title":"【港股异动 | 联邦制药(03933.HK)涨超6%逼近前高 】联邦制药(03933.HK)再涨超6%，盘中高见12.5港元，逼近历史前高12.62港元。截至发稿，涨4.94%，报12.32港元，成交额7467.86万港元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2493261607","media":"金融界","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493261607?lang=zh_cn&edition=full","pubTime":"2024-12-24 11:52","pubTimestamp":1735012347,"startTime":"0","endTime":"0","summary":"联邦制药(03933.HK)再涨超6%，盘中高见12.5港元，逼近历史前高12.62港元。截至发稿，涨4.94%，报12.32港元，成交额7467.86万港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2024/12/24115246736405.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2493725034","title":"港股异动 | 联邦制药(03933)涨超6%逼近前高 原料药价格景气度有望持续提升 高盛上调销售和盈利预测","url":"https://stock-news.laohu8.com/highlight/detail?id=2493725034","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493725034?lang=zh_cn&edition=full","pubTime":"2024-12-24 11:37","pubTimestamp":1735011449,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，联邦制药再涨超6%，盘中高见12.5港元，逼近历史前高12.62港元。太平洋证券指出，中国原料药板块在建工程规模4年来首次下滑，印度原料药园区建设期限延后，行业供给端产能扩张放缓，同时补库新周期叠加专利悬崖有望带动需求增长，产品价格景气度有望持续提升。该行对联邦制药明年的价格趋势有更正面的预期，上调销售和盈利预测。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1228849.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 联邦制药(03933)涨超6%逼近前高 原料药价格景气度有望持续提升 高盛上调销售和盈利预测","news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2237443465.HKD","BK1191","BK4533","LU1668664300.SGD","IE00BFXG1179.USD","IE0004091025.USD","BK4585","LU2237443622.USD","LU0106831901.USD","LU2237438978.USD","IE0034235188.USD","LU1791807156.HKD","LU2237443978.SGD","IE00BSNM7G36.USD","LU2237443549.SGD","LU2237443895.HKD","IE00B19Z3581.USD","03933","BK4588","IE0004086264.USD","BK4516","IE0002270589.USD","LU2237443382.USD","IE00B19Z3B42.SGD","BK4127","BK4552","BK4550","BK4504"],"gpt_icon":0},{"id":"2493747816","title":"联邦制药盘中异动 股价大涨5.11%报12.340港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493747816","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493747816?lang=zh_cn&edition=full","pubTime":"2024-12-24 10:04","pubTimestamp":1735005870,"startTime":"0","endTime":"0","summary":"2024年12月24日早盘10时04分，联邦制药股票出现波动，股价大幅拉升5.11%。截至发稿，该股报12.340港元/股，成交量168.302万股，换手率0.09%，振幅6.47%。资金方面，该股资金流入1630.22万港元，流出235.36万港元。联邦制药股票所在的药品行业中，整体涨幅为0.03%。其相关个股中，德琪医药-B、中智药业、联康生物科技集团涨幅较大，振幅较大的相关个股有中生联合、德琪医药-B、联邦制药，振幅分别为11.67%、8.20%、6.13%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122410043095eae87e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122410043095eae87e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2493826507","title":"港股异动 | 联邦制药(03933)盘中涨超6% 莫匹罗星软膏近期获批上市 高盛预计旗下产品定价趋势稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=2493826507","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493826507?lang=zh_cn&edition=full","pubTime":"2024-12-23 15:39","pubTimestamp":1734939561,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，联邦制药盘中涨超6%，截至发稿，涨4.07%，报11.76港元，成交额8454.66万港元。本次获批将进一步有助于公司巩固于抗感染领域的优势地位。高盛此前指出，对联邦制药明年的价格趋势有更正面的预期，上调2025、2026年销售额和盈利预测。该行指出，根据Wind数据，联邦制药旗下青霉素G和6-APA维持有利的定价，并在历史高位，虽然6-APA在11月时价格出现了一些轻微的波动。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1228342.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 联邦制药(03933)盘中涨超6% 莫匹罗星软膏近期获批上市 高盛预计旗下产品定价趋势稳定","news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2237443465.HKD","BK4516","BK4588","IE00BSNM7G36.USD","LU1791807156.HKD","LU2237438978.USD","LU2237443895.HKD","BK4552","IE0002270589.USD","LU1668664300.SGD","BK1191","BK4127","BK4550","LU2237443978.SGD","LU2237443382.USD","BK4585","IE0034235188.USD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","LU2237443549.SGD","03933","LU0106831901.USD","BK4533","IE0004091025.USD","IE0004086264.USD","BK4504","LU2237443622.USD","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2493023392","title":"《大行》野村列出中资“持续跑赢”股份名单(表)","url":"https://stock-news.laohu8.com/highlight/detail?id=2493023392","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493023392?lang=zh_cn&edition=full","pubTime":"2024-12-23 12:11","pubTimestamp":1734927060,"startTime":"0","endTime":"0","summary":"野村发表亚洲股市报告，列出中资“持续跑赢”股份名单，条件包括上市时间至少六年、日均成交逾50万美元、自2015 年/上市日期以来相对优于基准及市值需逾5亿美元。野村亦表示，虽然过去的表现并不能保证未来的结果，但该行认为，这些过去表现优异的股份仍值得希望于亚洲股市获得优势的投资者进行更仔细的审视。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205150910194_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205150910194_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1405905/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["00981","01585","HTCD.SI","LU0348825331.USD","00700","00669","01735","CRHKY","02020","02313","00291","06066","01882","01093","02899","01381","82020","03968","BK1214","02319","TCEHY","01913","BK1198","03993","LU2362540622.SGD","01908","01513","80291","02331","LU1102505929.USD","82331","03143","01030","01773","00921","06198","LU1044876610.USD","LU1770034418.SGD","01088","LU0061477393.USD","80700","LU1734074674.USD","01308","LNNGY","LU0254981946.USD","01208","ANPDY","03808","LU0700851271.USD","03933"],"gpt_icon":1},{"id":"2493507270","title":"联邦制药盘中异动 早盘股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493507270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493507270?lang=zh_cn&edition=full","pubTime":"2024-12-23 09:51","pubTimestamp":1734918660,"startTime":"0","endTime":"0","summary":"2024年12月23日早盘09时51分，联邦制药股票出现异动，股价急速拉升5.13%。截至发稿，该股报11.880港元/股，成交量175.4万股，换手率0.10%，振幅5.13%。联邦制药股票所在的药品行业中，整体涨幅为0.01%。其相关个股中，华控康泰、联邦制药、海王英特龙涨幅较大，振幅较大的相关个股有君圣泰医药-B、草姬集团、海王英特龙，振幅分别为13.16%、10.23%、8.13%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122309510095eac778&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122309510095eac778&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2493270846","title":"联邦制药(03933)上涨5.13%，报11.88元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2493270846","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493270846?lang=zh_cn&edition=full","pubTime":"2024-12-23 09:51","pubTimestamp":1734918660,"startTime":"0","endTime":"0","summary":"12月23日，联邦制药(03933)盘中上涨5.13%，截至09:51，报11.88元/股，成交2039.47万元。联邦制药国际控股有限公司主要从事药品的研发、生产和销售，拥有制剂、原料、生物、动保四大业务板块，九家生产研发实体的综合性制药集团，全球销售网络覆盖，员工人数达到15000余人。在荣膺多项行业荣誉基础上，公司在2022年的中国化药企业和医药工业百强排行榜分别位居第16和27名。截至2024年中报，联邦制药营业总收入71.76亿元、净利润14.91亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/23095146685047.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2493270245","title":"联邦制药(03933)股价上升5.133%，现价港币$11.88","url":"https://stock-news.laohu8.com/highlight/detail?id=2493270245","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493270245?lang=zh_cn&edition=full","pubTime":"2024-12-23 09:50","pubTimestamp":1734918600,"startTime":"0","endTime":"0","summary":"[上升股]联邦制药(03933) 股价在上午09:50比前收市价上升5.133%，现股价为港币$11.88。至目前为止，今日最高价为$11.88，而最低价为$11.3。总成交量为175.4万股，总成交金额为港币$2.039千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR241223459/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2492979262","title":"联邦制药12月18日主力资金流入289万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2492979262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492979262?lang=zh_cn&edition=full","pubTime":"2024-12-18 16:15","pubTimestamp":1734509714,"startTime":"0","endTime":"0","summary":"12月18日, 联邦制药股价涨0.70%，报收11.46元，成交金额4348万元，换手率0.21%，振幅3.16%，量比0.84。联邦制药今日主力资金净流入289万元，连续3日净流入，上一交易日主力净流入155万元，今日环比增加86.45%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为33.33%，平均涨幅为1.87%。该股近5个交易日下跌0.69%，主力资金累计净流入666万元；近20日主力资金累计净流入2600万元，其中净流入天数为14日。该股主力净额占比0.01%，港股市场排名228/2653。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218161522ab814704&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218161522ab814704&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2490823279","title":"《半日速报》恒指升346点; 恒生科技指数升115点 平安升逾3% 万洲、大新金融、达势股份、联邦制药、特海国际创新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2490823279","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490823279?lang=zh_cn&edition=full","pubTime":"2024-12-12 12:12","pubTimestamp":1733976720,"startTime":"0","endTime":"0","summary":"恒指半日收20,501点，升346点或1.7%。恒生科技指数报4,647点，升115点或2.6%。国指升148点或2.0%，报7,397点。沽空资料截至 2024-12-11 16:25。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190213170700928_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190213170700928_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1403648/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["90076","01405","MHImain","BK1191","MCHmain","HSTECH","HSI","BK1233","HHImain","00440","BK1231","HSImain","03933","09658","02833","513600"],"gpt_icon":0},{"id":"2490388038","title":"高盛：对联邦制药明年价格趋势有更正面预期 目标价升至10.25港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490388038","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490388038?lang=zh_cn&edition=full","pubTime":"2024-12-11 16:21","pubTimestamp":1733905260,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　高盛发布研究报告称，由于对联邦制药（03933）明年的价格趋势有更正面的预期，将2025同2026年销售额和盈利预测分别上调 8.1%/4.7%和17.4%/10%。目标价由9.31港元升至10.25港元。\n　　根据Wind数据，联邦制药旗下青霉素G和6-APA维持有利的定价，并在历史高位，虽然6-APA在11月时价格出现了一些轻微的波动。该行预期未来几季公司的定价趋势仍将保持韧性，因为一家印度主要制药商的产能扩张速度较预期缓慢。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：史丽君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2024-12-11/doc-inczarzk7546165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["03933"],"gpt_icon":0},{"id":"2490882930","title":"高盛：对联邦制药(03933)明年价格趋势有更正面预期 目标价升至10.25港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490882930","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490882930?lang=zh_cn&edition=full","pubTime":"2024-12-11 15:42","pubTimestamp":1733902951,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，高盛发布研究报告称，由于对联邦制药(03933)明年的价格趋势有更正面的预期，将2025同2026年销售额和盈利预测分别上调 8.1%/4.7%和17.4%/10%。目标价由9.31港元升至10.25港元。根据Wind数据，联邦制药旗下青霉素G和6-APA维持有利的定价，并在历史高位，虽然6-APA在11月时价格出现了一些轻微的波动。该行预期未来几季公司的定价趋势仍将保持韧性，因为一家印度主要制药商的产能扩张速度较预期缓慢。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1223433.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03933"],"gpt_icon":0},{"id":"2490889654","title":"《大行》高盛升联邦制药(03933.HK)目标价至10.25元  上调销售和盈利预测","url":"https://stock-news.laohu8.com/highlight/detail?id=2490889654","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490889654?lang=zh_cn&edition=full","pubTime":"2024-12-11 14:50","pubTimestamp":1733899800,"startTime":"0","endTime":"0","summary":"高盛发表报告指，根据Wind数据，联邦制药(03933.HK) 旗下青霉素G和6-APA维持有利的定价，并在历史高位，虽然6-APA在11月时价格出现了一些轻微的波动。该行预期未来几季公司的定价趋势仍将保持韧性，因为一家印度主要制药商的产能扩张速度较预期缓慢。高盛指，由于对公司明年的价格趋势有更正面的预期，将2025同2026年销售额和盈利预测分别上调 8.1%/4.7%和 17.4%/10%。目标价由9.31元升至10.25元。(ha/u)(港股报价延迟最少十五分钟。沽空资料截至 2024-12-11 12:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210705160257417_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210705160257417_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1403352/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["03933"],"gpt_icon":0},{"id":"2490798637","title":"联邦制药早盘涨逾3% 近日抗感染产品莫匹罗星软膏获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2490798637","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490798637?lang=zh_cn&edition=full","pubTime":"2024-12-09 10:10","pubTimestamp":1733710218,"startTime":"0","endTime":"0","summary":"联邦制药（03933）早盘上涨2.84%，现报11.58港元，成交额3341.36万港元。\n　　12月4日，联邦制药发布公告，公司全资附属公司珠海联邦制药股份有限公司中山分公司申报的莫匹罗星软膏（规格：2%（5g：0.1g））通过中国国家药品监督管理局上市审批，药品批准文号：国药准字 H20249649。本次获批将进一步有助于公司巩固于抗感染领域的优势地位。公司将持续致力于新产品研发，为公司及其股东创造更大收益。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-12-09/doc-incyvnxx6084446.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-12-09/doc-incyvnxx6084446.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2490676040","title":"港股异动 | 联邦制药(03933)涨超3% 近日抗感染产品莫匹罗星软膏获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2490676040","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490676040?lang=zh_cn&edition=full","pubTime":"2024-12-09 10:01","pubTimestamp":1733709698,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，联邦制药涨超3%，截至发稿，涨3.73%，报11.68港元，成交额3047.87万港元。消息面上，12月4日，联邦制药发布公告，公司全资附属公司珠海联邦制药股份有限公司中山分公司申报的莫匹罗星软膏通过中国国家药品监督管理局上市审批，药品批准文号：国药准字 H20249649。本次获批将进一步有助于公司巩固于抗感染领域的优势地位。公告称，莫匹罗星软膏是一种广谱抗生素，适用于革兰阳性球菌引起的皮肤感染，属甲类OTC皮肤外用药。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1221950.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 联邦制药(03933)涨超3% 近日抗感染产品莫匹罗星软膏获批上市","news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2490767419","title":"联邦制药盘中异动 股价大涨5.15%报11.840港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490767419","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490767419?lang=zh_cn&edition=full","pubTime":"2024-12-09 09:34","pubTimestamp":1733708043,"startTime":"0","endTime":"0","summary":"2024年12月09日早盘09时34分，联邦制药股票出现异动，股价大幅拉升5.15%。截至发稿，该股报11.840港元/股，成交量128.825万股，换手率0.07%，振幅5.33%。资金方面，该股资金流入895.464万港元，流出517.196万港元。联邦制药股票所在的药品行业中，整体涨幅为0.23%。其相关个股中，康龙化成、凯莱英、联邦制药涨幅较大，振幅较大的相关个股有联邦制药、凯莱英、康龙化成，振幅分别为5.33%、4.37%、4.37%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120909340498e663b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120909340498e663b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2489477755","title":"联邦制药盘中异动 大幅拉升5.03%报11.280港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489477755","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489477755?lang=zh_cn&edition=full","pubTime":"2024-12-06 14:41","pubTimestamp":1733467294,"startTime":"0","endTime":"0","summary":"2024年12月06日下午盘14时41分，联邦制药股票出现波动，股价急速拉升5.03%。截至发稿，该股报11.280港元/股，成交量370.305万股，换手率0.20%，振幅5.03%。资金方面，该股资金流入2394.59万港元，流出1184.89万港元。联邦制药股票所在的药品行业中，整体涨幅为0.18%。其相关个股中，衍生集团、康龙化成、顺腾国际控股涨幅较大，振幅较大的相关个股有顺腾国际控股、德琪医药-B、康龙化成，振幅分别为10.71%、10.45%、9.31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120614413498e5cafc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120614413498e5cafc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2489471136","title":"联邦制药(03933)上涨5.03%，报11.28元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2489471136","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489471136?lang=zh_cn&edition=full","pubTime":"2024-12-06 14:41","pubTimestamp":1733467294,"startTime":"0","endTime":"0","summary":"12月6日，联邦制药(03933)盘中上涨5.03%，截至14:41，报11.28元/股，成交4090.09万元。联邦制药国际控股有限公司主要从事药品的研发、生产和销售，拥有制剂、原料、生物、动保四大业务板块，九家生产研发实体的综合性制药集团，全球销售网络覆盖，员工人数达到15000余人。在荣膺多项行业荣誉基础上，公司在2022年的中国化药企业和医药工业百强排行榜分别位居第16和27名。截至2024年中报，联邦制药营业总收入71.76亿元、净利润14.91亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/06144146091516.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2489074104","title":"联邦制药全资子公司获批莫匹罗星软膏上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2489074104","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489074104?lang=zh_cn&edition=full","pubTime":"2024-12-05 13:18","pubTimestamp":1733375901,"startTime":"0","endTime":"0","summary":"财中社12月5日电联邦制药（03933）发布公告，宣布其全资子公司珠海联邦制药股份有限公司中山分公司申报的莫匹罗星软膏（规格：2%（5g:0.1g））已通过中国国家药品监督管理局的上市审批，药品批准文号为国药准字H20249649。莫匹罗星软膏是一种广谱抗生素，适用于革兰阳性球菌引起的皮肤感染，属于甲类OTC皮肤外用药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412053260129215.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2489111301","title":"联邦制药(03933.HK)莫匹罗星软膏通过国家药监局上市审批","url":"https://stock-news.laohu8.com/highlight/detail?id=2489111301","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489111301?lang=zh_cn&edition=full","pubTime":"2024-12-05 00:41","pubTimestamp":1733330460,"startTime":"0","endTime":"0","summary":"联邦制药(03933.HK) 公布，全资附属珠海联邦制药申报的莫匹罗星软膏通过中国国家药品监督管理局上市审批。莫匹罗星软膏是一种广谱抗生素，适用于革兰阳性球菌引起的皮肤感染，属甲类OTC皮肤外用药。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-12-04 16:25。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210705160258804_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210705160258804_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1401855/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","03933"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tul.com.cn","stockEarnings":[{"period":"1week","weight":0.085},{"period":"1month","weight":0.1766},{"period":"3month","weight":0.2587},{"period":"6month","weight":0.6026},{"period":"1year","weight":0.9249},{"period":"ytd","weight":0.8838}],"compareEarnings":[{"period":"1week","weight":0.0187},{"period":"1month","weight":0.0249},{"period":"3month","weight":-0.0263},{"period":"6month","weight":0.1339},{"period":"1year","weight":0.1788},{"period":"ytd","weight":0.1785}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"联邦制药国际控股有限公司是一家投资控股公司，主要从事销售中间体产品、原料药及制剂产品业务。该公司通过三个业务部门运营业务。中间体部从事销售中间体产品业务。原料药部从事销售原料药业务。制剂产品部从事销售抗生素制剂产品、非抗生素制剂产品及空心胶囊业务。该公司通过其子公司还从事制造及销售有机化肥业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.352941,"avgChangeRate":-0.03467},{"month":2,"riseRate":0.705882,"avgChangeRate":0.07139},{"month":3,"riseRate":0.647059,"avgChangeRate":0.036146},{"month":4,"riseRate":0.647059,"avgChangeRate":0.088822},{"month":5,"riseRate":0.647059,"avgChangeRate":0.04001},{"month":6,"riseRate":0.235294,"avgChangeRate":-0.014741},{"month":7,"riseRate":0.5,"avgChangeRate":0.011841},{"month":8,"riseRate":0.444444,"avgChangeRate":0.0248},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.006812},{"month":10,"riseRate":0.666667,"avgChangeRate":0.008091},{"month":11,"riseRate":0.444444,"avgChangeRate":-0.025363},{"month":12,"riseRate":0.444444,"avgChangeRate":0.016395}],"exchange":"SEHK","name":"联邦制药","nameEN":"UNITED LAB"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"联邦制药(03933)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供联邦制药(03933)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"联邦制药,03933,联邦制药股票,联邦制药股票老虎,联邦制药股票老虎国际,联邦制药行情,联邦制药股票行情,联邦制药股价,联邦制药股市,联邦制药股票价格,联邦制药股票交易,联邦制药股票购买,联邦制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"联邦制药(03933)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供联邦制药(03933)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}